On a quest to treat newly diagnosed lymphoma patients, Roche teases positive pivotal data
A couple of years ago, as generics were eating into the sales of its top three cancer drugs, Roche snagged an early approval for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
